- $2.04bn
- $1.56bn
- $419.50m
Annual income statement for Avepoint, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 192 | 232 | 272 | 330 | 419 |
| Cost of Revenue | |||||
| Gross Profit | 139 | 166 | 194 | 248 | 311 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 245 | 273 | 287 | 323 | 386 |
| Operating Profit | -53.5 | -41.1 | -15.4 | 7.17 | 33 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.8 | -33.6 | -18.6 | -24.4 | 40.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -33.2 | -38.7 | -21.5 | -29.1 | 35.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -35.2 | -41.6 | -21.7 | -29.1 | 34.8 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -68.1 | -41.6 | -21.7 | -29.1 | 34.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.481 | -0.229 | -0.119 | -0.158 | 0.152 |